Hyperkalemia
Hyperkalemia is defined as a blood potassium level higher than 5.5 mmol/L, and severe hyperkalemia is defined as a level greater than 7.0 mmol/L. Hyperkalemia often causes sudden cardiac arrest with few or no symptoms, so it should be detected and treated early.
Related Drugs
Sodium Lactate Injection
Indication: Used to correct metabolic acidosis, buffer in peritoneal dialysis fluid, hyperkalemia with severe arrhythmia and widened QRS wave.
Manufacturer:
Chengdu Brilliant Pharmaceutical Co., Ltd.
Sodium Lactate Injection
Indication: Used to correct metabolic acidosis, buffer in peritoneal dialysis fluid, hyperkalemia with severe arrhythmia and widened QRS wave.
Manufacturer:
Chongqing Dikang Changjiang Pharmaceutical Co., Ltd.
Sodium Lactate Injection
Indication: Used to correct metabolic acidosis, buffer in peritoneal dialysis fluid, hyperkalemia with severe arrhythmia and widened QRS wave.
Manufacturer:
Wuhan Binhu Shuanghe Pharmaceutical Co., Ltd.
Sodium Potassium Glucose Injection
Indication: 1. Replenish energy and body fluids; used for insufficient food intake or large amounts of body fluid loss (such as vomiting, diarrhea, etc.) caused by various reasons, total intravenous nutrition, and starvation ketosis; 2. Used to treat hypoglycemia; 3. Used to treat hyperkalemia; 4. Hypertonic solutions are used as tissue dehydrating agents; 5. Used to prepare peritoneal dialysis fluids; 6. Used as drug diluents; 7. Used for intravenous glucose tolerance tests; 8. Used to prepare GIK (polarizing fluid) fluids.
Sodium lactate solution
Indication: Used to correct metabolic acidosis, buffer in peritoneal dialysis fluid, hyperkalemia with severe arrhythmia and widened QRS wave.
Manufacturer:
Luoyang Fuyue Industrial Co., Ltd.
Sodium lactate solution
Indication: Used to correct metabolic acidosis, buffer in peritoneal dialysis fluid, hyperkalemia with severe arrhythmia and widened QRS wave.
Manufacturer:
Wuxi Fortune Pharmaceutical Co., Ltd.
Sodium lactate solution
Indication: Used to correct metabolic acidosis, buffer in peritoneal dialysis fluid, hyperkalemia with severe arrhythmia and widened QRS wave.
Manufacturer:
Luoyang Longmen Pharmaceutical Co., Ltd.
Calcium Polystyrene Sulfonate Powder
Indication: Potassium-lowering drugs are mainly used to prevent and treat hyperkalemia in patients with acute and chronic renal insufficiency and renal failure.
Glucose injection
Indication: Replenish energy and body fluids, hypoglycemia, hyperkalemia, hypertonic solution used as tissue dehydrating agent, preparation of peritoneal dialysis solution, drug diluent, intravenous glucose tolerance test, for the preparation of GIK (polarizing solution) solution.
Manufacturer:
Anhu Welman Pharmaceut Icai Cd.ltd